AD in Infancy: Diagnostic Advice and Treatment Tips

WASHINGTON — Atopic dermatitis (AD) in childhood presents most commonly by age 1 and typically begins on the face, and while it can make infants “miserable,” caregiver and provider concerns about treatment on the face and at such a young age mean it is often “woefully undertreated,” Robert Sidbury, MD, MPH, said at the annual Revolutionizing Atopic Dermatitis conference. Dr Robert Sidbury Identifying […]

» Read more

Placebo effect in technical applications increases risk-taking behavior

Human augmentation technologies refer to technological aids that enhance human abilities. They include things like exoskeletons, but also augmented reality headsets. A study at the Chair of Human-Centered Ubiquitous Media at LMU has now shown that users have high expectations of the effects of these technologies. As soon as they believe that AI is enhancing their cognitive abilities, they increase […]

» Read more

Food for thought: How your mindset can make healthy food more alluring on social media

In today’s world, our diets are often packed with fats and sugars. Our ancient instinct to crave calorie-rich foods, which once helped us survive, now leads to harmful health side-effects. To counteract this, food content creators on social media have been trying to push healthy eating and healthy eating content. But here’s the kicker—this content doesn’t get much engagement. Instead, […]

» Read more

AxSpA-IBD: AxSpA Remission on TNFi Seen in Half of Patients

CLEVELAND – About half (52%) of patients living with both axial spondyloarthritis and inflammatory bowel disease (IBD) reached clinical remission of axSpA at 12 months after starting a tumor necrosis factor inhibitor (TNFi), researchers have found. The disease course for axSpA among patients with IBD who start anti-TNF agents is not well understood. Rahul S. Dalal, MD, an advanced fellow in […]

» Read more

This panel will decide whose medicine to make affordable. Its choice will be tricky.

Catherine Reitzel's multiple sclerosis medication costs nearly $100,000 a year. Kris Garcia relies on a drug for a blood-clotting disorder that runs $10,000 for a three-day supply. And Mariana Marquez-Farmer would likely die within days without her monthly $300 vial of insulin. At best, a Colorado panel of medical and pharmacy experts seeking to cut the costs of expensive drugs […]

» Read more

Bridging the Gap between Academia and Industry: The Power of Collaboration in Life Sciences

Thought LeadersDr. Sinéad Knight Principal Scientist and Section HeadSygnature Discovery In this behind-the-scenes interview, we speak to Dr. Sinéad Knight, chair of SLAS Europe 2023, about this years programme, highlighting the key topics and incredible speakers presenting at the show. Please can you introduce yourself and tell us what inspired your career within the life sciences? I'm Sinéad Knight, originally from Tipperary […]

» Read more
1 134 135 136 137 138 1,330